Skip to main content
Signal8

NovAccess Global Inc. (XSNX)

Sector: Biotechnology

Industry: Biotechnology

NovAccess Global Inc. logo

NovAccess Global Inc.

OTC:XSNXHealthcare
$0.0001
CLOSED
Mkt Cap$6K
EV-
Float26.32M
O/S61.65M
VOL200 sh
$ Vol$0
RVOL1.00×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
NovAccess Global Inc. logoOTC:XSNXClosed$0.0001
Historical Data
DateOpenHighLowCloseVolume
Nov 11, 20260.00010.00010.00010.0001200
Nov 10, 20260.00010.00010.00010.0001202
Oct 12, 20260.00010.00010.00010.0001158
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About

Operating as a biopharmaceutical firm, NovAccess Global Inc. focuses on developing innovative immunotherapies to treat individuals with brain tumors across the United States. Their primary expertise is in pioneering research that leverages a patient's own immune system to target and eliminate cancerous cells.

The company, founded in 1997, has its headquarters situated in Chesterland, Ohio.

Key Metrics
Market Cap$6,165
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 61.65M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryUSUS
IPO DateSep 21, 1998
Shares Outstanding61.65M
Authorized Shares
Float26.32M
52-Week Range
$0.0001$0.0005
$0.0001(0th percentile)
Volume
Average Daily Volume201
200 today vs 201 avg(-0%)

30d Avg

201

60d Avg

187

90d Avg

2.17K

Earnings
Dividend History
No dividend history available

NovAccess Global Inc. (OTC: XSNX) traded at $0.0001 on Nov 11, 2026. 52-week range: $0.0001 to $0.0005. The company is in the Healthcare sector (Biotechnology).